CPAY vs ZS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CPAY · Corpay$429.84 ▼ 1.02%
ZS · Zscaler$194.82 ▼ 5.29%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CPAY +49.8%
- ZS -30.5%
Head to head
| Metric | CPAY | ZS |
|---|---|---|
| Price | $429.84 | $194.82 |
| Change today | ▼ 1.02% | ▼ 5.29% |
| Market cap | $27.50B | $31.77B |
| Return, 3 months | +3.8% | +10.7% |
| Return, year to date | +42.8% | -13.4% |
| Return, 1 year | +48.8% | -29.2% |
| P/E (TTM) | 23.6 | – |
| P/B | 8.3 | 12.2 |
| P/E percentile vs own 5y | 78th | 29th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +17.9% | +24.9% |
| Net profit growth (YoY) | +37.3% | +80.8% |
| Gross margin | 78.9% | 76.8% |
| Operating margin | 40.4% | -3.6% |
| Net margin | 23.7% | -1.9% |
| Return on equity | 33.7% | -2.9% |
| Analyst target vs. price | +16.3% | +25.6% |
| Analyst buy share | 75% | 91% |
| RSI (14) | 49 | 42 |
| 30-day volatility | 32.3% | 62.6% |
| Max drawdown, 1 year | -20.2% | -64.4% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ZS is the largest of the group by market value.
- CPAY has returned the most over the past year.
- ZS is growing revenue fastest.
- CPAY keeps the most profit per dollar of sales.
- CPAY has been the calmest stock over the last 30 days.